Invokana (canaglifozin) For Type 2 Diabetes Approved By FDA

The FDA has approved Johnson & Johnson's Invokana (canaglifozin) tablets, to be used with exercise and diet, for adults with type 2 diabetes to improve glycemic control. Type 2 diabetes affects approximately 24 million Americans. Patients eventually tend to have complications from high blood sugar levels, including kidney damage, nerve damage, blindness and heart disease. Mary Parks, M.D...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Diabetes Source Type: news